Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty
Maria Tikhonenko1, Todd A Lydic, Yun Wang
1Department of Physiology, Michigan State University, East Lansing, Michigan, USA.
Objective:
The results of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort study revealed a strong association between dyslipidemia and the development of diabetic retinopathy. However, there are no experimental data on retinal fatty acid metabolism in diabetes. This study determined retinal-specific fatty acid metabolism in control and diabetic animals.
Research Design And Methods:
Tissue gene and protein expression profiles were determined by quantitative RT-PCR and Western blot in control and streptozotocin-induced diabetic rats at 3-6 weeks of diabetes. Fatty acid profiles were assessed by reverse-phase high-performance liquid chromatography, and phospholipid analysis was performed by nano-electrospray ionization tandem mass spectrometry.
Results:
We found a dramatic difference between retinal and liver elongase and desaturase profiles with high elongase and low desaturase gene expression in the retina compared with liver. Elovl4, an elongase expressed in the retina but not in the liver, showed the greatest expression level among retinal elongases, followed by Elovl2, Elovl1, and Elovl6. Importantly, early-stage diabetes induced a marked decrease in retinal expression levels of Elovl4, Elovl2, and Elovl6. Diabetes-induced downregulation of retinal elongases translated into a significant decrease in total retinal docosahexaenoic acid, as well as decreased incorporation of very-long-chain polyunsaturated fatty acids (PUFAs), particularly 32:6n3, into retinal phosphatidylcholine. This decrease in n3 PUFAs was coupled with inflammatory status in diabetic retina, reflected by an increase in gene expression of proinflammatory markers interleukin-6, vascular endothelial growth factor, and intercellular adhesion molecule-1.
Conclusions:
This is the first comprehensive study demonstrating diabetes-induced changes in retinal fatty acid metabolism. Normalization of retinal fatty acid levels by dietary means or/and modulating expression of elongases could represent a potential therapeutic target for diabetes-induced retinal inflammation.
Insights
Diabetes alters retinal fatty acid metabolism, decreasing essential omega-3 polyunsaturated fatty acids (PUFAs) and increasing inflammation. Modulating elongase expression may offer a therapeutic target for diabetic retinopathy.
Area of Science:
- Biochemistry
- Ophthalmology
- Metabolic Research
Background:
- Dyslipidemia is linked to diabetic retinopathy, but retinal fatty acid metabolism in diabetes remains unexplored.
- Previous studies highlight the association between dyslipidemia and diabetic retinopathy development.
Purpose of the Study:
- To investigate retinal-specific fatty acid metabolism in a preclinical model of diabetes.
- To determine the impact of diabetes on retinal gene and protein expression related to fatty acid synthesis.
Main Methods:
- Utilized streptozotocin-induced diabetic rats, analyzing tissue gene and protein expression via RT-PCR and Western blot.
- Assessed fatty acid profiles using high-performance liquid chromatography and phospholipid analysis via mass spectrometry.
Main Results:
- Retinal elongase and desaturase gene expression differed significantly from the liver, with Elovl4 being highly expressed in the retina.
- Early-stage diabetes markedly decreased retinal elongase expression (Elovl4, Elovl2, Elovl6), reducing docosahexaenoic acid and n3 PUFA incorporation into retinal phosphatidylcholine.
- Diabetic retinas showed increased expression of inflammatory markers (IL-6, VEGF, ICAM-1), correlating with reduced n3 PUFAs.
Conclusions:
- This study provides the first comprehensive analysis of diabetes-induced changes in retinal fatty acid metabolism.
- Targeting retinal fatty acid levels through diet or modulating elongase expression presents a potential therapeutic strategy for diabetic retinal inflammation.
More Related Videos
10:59Label-Free Imaging of Lipid Storage Dynamics in Caenorhabditis elegans using Stimulated Raman Scattering Microscopy
Published on: May 28, 2021
06:16LipidUNet-Machine Learning-Based Method of Characterization and Quantification of Lipid Deposits Using iPSC-Derived Retinal Pigment Epithelium
Published on: July 28, 2023